Suzetrigine for Pain from Diabetic Nerve Damage
Evaluation of Efficacy and Safety of Suzetrigine for Pain Associated With Diabetic Peripheral Neuropathy
- Age
- 18 – 80
- Sex
- Any
- Trial phase
- Phase 3
- Study type
- Interventional
- Purpose
- Treatment
- Participants needed
- 1,100 (estimated)
- Sponsor
- Vertex Pharmaceuticals Incorporated · Industry
This trial is looking for people who have pain in their legs due to diabetic nerve damage. Participants will take a medication called Suzetrigine and help researchers understand how well it works and how safe it is.
You may be able to join if
- I weigh at least 45 kilograms.
- I have a BMI between 18.0 and 40.0.
- I have been diagnosed with diabetes type 1 or type 2.
- I have pain in both legs due to diabetic peripheral neuropathy.
- My average pain score is between 4 and 9.
You may not be able to join if
- I missed more than 3 daily pain score checks last week.
- I have any other sensory problems besides diabetic neuropathy.
Summarized in plain language from this trial's official eligibility criteria. The full criteria are further down this page — only the research team can confirm whether you qualify.
Think this trial could be right for you?
Answer a few quick questions to see if you may meet the eligibility requirements.
Check Your EligibilityThe purpose of this study is to evaluate the efficacy, safety, and tolerability of Suzetrigine (SUZ) in participants with pain associated with diabetic peripheral neuropathy (DPN).
Loading trial locations…